The Power of Triple Agonism Retatrutide's unique strength lies in its ability to engage three distinct but interconnected metabolic pathways: GIP (Glucose-dependent insulinotropic polypeptide) Receptor: GIP is an incretin hormone that stimulates insulin secretion in a glucose-dependent manner and plays a role in fat metabolism
Viking Therapeutics Sector: Dual and triple agonists for obesity, metabolic, and liver disease HQ: San Diego, CA Year Founded: 2012 Origin Story: The company built its pipeline around small molecule and peptide candidates licensed from academic and pharma sources, eventually advancing VK2735, a dual GLP-1/GIP receptor agonist designed to be the first such therapy available in both oral and injectable formulations
But for someone who had tried countless approaches before, this was the first thing that produced lasting results
They are paraphrased, anecdotal, and not controlled data community impressions frequently diverge from what randomised trials measure
Weeks 5-12: Primary Adaptation Complete Most users find GI side effects substantially reduced by week 5-6
Several chemotherapies, particularly platinum-based chemotherapies, were excluded due to insufficient EMA product information
